Yeonji Kim

3 weeks ago | outsourcedpharma.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu |Louis Garguilo

By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.

3 weeks ago | cellandgene.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu

By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.